Simvastatin offers new prospects for the treatment of Duchenne muscular dystrophy

References

• Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A 1993; 90:3710-4; PMID:8475120; http://dx.doi.org/10.1073/pnas.90.8.3710
   Google Scholar
• Bello L, Gordish-Dressman H, Morgenroth LP, Henricson EK, Duong T, Hoffman EP, Cnaan A, McDonald CM, Investigators C. Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study. Neurol 2015; 85:1048-55; PMID:26311750; http://dx.doi.org/10.1212/WNL.0000000000001950
   Google Scholar
• Bianchi ML, Biggar D, Bushby K, Rogol AD, Rutter MM, Tseng B. Endocrine aspects of Duchenne muscular dystrophy. Neuromuscul Disord 2011; 21:298-303; PMID:21353552; http://dx.doi.org/10.1016/j.nmd.2011.02.006
   Google Scholar
• Kole R, Krieg AM. Exon skipping therapy for Duchenne muscular dystrophy. Adv Drug Deliv Rev 2015; 87:104-7; PMID:25980936; http://dx.doi.org/10.1016/j.addr.2015.05.008
   Google Scholar
• Aartsma-Rus A, Ferlini A, Goemans N, Pasmooij AM, Wells DJ, Bushby K, Vroom E, Balabanov P. Translational and regulatory challenges for exon skipping therapies. Hum Gene Ther 2014; 25:885-92; PMID:25184444; http://dx.doi.org/10.1089/hum.2014.086
   Google Scholar
• Hoffman EP, McNally EM. Exon-skipping therapy: a roadblock, detour, or bump in the road? Sci Transl Med 2014; 6:230fs14; PMID:24695683; http://dx.doi.org/10.1126/scitranslmed.3008873
   Google Scholar
• Percival JM, Whitehead NP, Adams ME, Adamo CM, Beavo JA, Froehner SC. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy. J Pathol 2012; 228:77-87; PMID:22653783
   Google Scholar
• Whitehead NP, Pham C, Gervasio OL, Allen DG. N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice. J Physiol 2008; 586:2003-14; PMID:18258657; http://dx.doi.org/10.1113/jphysiol.2007.148338
   Google Scholar
• Whitehead NP, Kim MJ, Bible KL, Adams ME, Froehner SC. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy. Proc Natl Acad Sci U S A 2015; 112:12864-9; PMID:26417069; http://dx.doi.org/10.1073/pnas.1509536112
   Google Scholar
• Antonopoulos AS, Margaritis M, Shirodaria C, Antoniades C. Translating the effects of statins: from redox regulation to suppression of vascular wall inflammation. Thromb Haemost 2012; 108:840-8; PMID:22872079; http://dx.doi.org/10.1160/TH12-05-0337
   Google Scholar
• Tanaka S, Fukumoto Y, Nochioka K, Minami T, Kudo S, Shiba N, Takai Y, Williams CL, Liao JK, Shimokawa H. Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation. Arterioscler Thromb Vasc Biol 2013; 33:1591-600; PMID:23640485; http://dx.doi.org/10.1161/ATVBAHA.112.300922
   Google Scholar
• Khairallah RJ, Shi G, Sbrana F, Prosser BL, Borroto C, Mazaitis MJ, Hoffman EP, Mahurkar A, Sachs F, Sun Y, et al. Microtubules underlie dysfunction in duchenne muscular dystrophy. Sci Signal 2012; 5:ra56; PMID:22871609; http://dx.doi.org/10.1126/scisignal.2002829
   Google Scholar
• Pal R, Palmieri M, Loehr JA, Li S, Abo-Zahrah R, Monroe TO, Thakur PB, Sardiello M, Rodney GG. Src-dependent impairment of autophagy by oxidative stress in a mouse model of Duchenne muscular dystrophy. Nat Commun 2014; 5:4425; PMID:25028121
   Google Scholar
• Shkryl VM, Martins AS, Ullrich ND, Nowycky MC, Niggli E, Shirokova N. Reciprocal amplification of ROS and Ca(2+) signals in stressed mdx dystrophic skeletal muscle fibers. Pflugers Arch 2009; 458:915-28; PMID:19387681; http://dx.doi.org/10.1007/s00424-009-0670-2
   Google Scholar
• Whitehead NP, Yeung EW, Froehner SC, Allen DG. Skeletal muscle NADPH oxidase is increased and triggers stretch-induced damage in the mdx mouse. PLoS One 2010; 5:e15354; PMID:21187957; http://dx.doi.org/10.1371/journal.pone.0015354
   Google Scholar
• Whitehead NP, Streamer M, Lusambili LI, Sachs F, Allen DG. Streptomycin reduces stretch-induced membrane permeability in muscles from mdx mice. Neuromuscul Disord 2006; 16:845-54; PMID:17005404; http://dx.doi.org/10.1016/j.nmd.2006.07.024
   Google Scholar
• Dalaklioglu S, Sahin P, Tasatargil A, Celik-Ozenci C. Pravastatin improves the impaired nitric oxide-mediated neurogenic and endothelium-dependent relaxation of corpus cavernosum in aged rats. Aging Male 2014; 17(4):259-66; PMID:24000938
   Google Scholar
• Pignatelli P, Carnevale R, Pastori D, Cangemi R, Napoleone L, Bartimoccia S, Nocella C, Basili S, Violi F. Immediate antioxidant and antiplatelet effect of atorvastatin via inhibition of Nox2. Circulation 2012; 126:92-103; PMID:22615342; http://dx.doi.org/10.1161/CIRCULATIONAHA.112.095554
   Google Scholar
• Lai Y, Thomas GD, Yue Y, Yang HT, Li D, Long C, Judge L, Bostick B, Chamberlain JS, Terjung RL, et al. Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. J Clin Invest 2009; 119:624-35; PMID:19229108; http://dx.doi.org/10.1172/JCI36612
   Google Scholar
• Godfrey C, Muses S, McClorey G, Wells KE, Coursindel T, Terry R, Betts C, Hammond S, O'Donovan L, Hildyard J, et al. How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse. Hum Mol Genet 2015; 24(15):4225-37
   Google Scholar
• Desguerre I, Mayer M, Leturcq F, Barbet JP, Gherardi RK, Christov C. Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation. J Neuropathol Exp Neurol 2009; 68:762-73; PMID:19535995; http://dx.doi.org/10.1097/NEN.0b013e3181aa31c2
   Google Scholar
• Peverelli L, Testolin S, Villa L, D'Amico A, Petrini S, Favero C, Magri F, Morandi L, Mora M, Mongini T, et al. Histologic muscular history in steroid-treated and untreated patients with Duchenne dystrophy. Neurol 2015; 85(21):1886-93; PMID:26497992
   Google Scholar
• Patel R, Nagueh SF, Tsybouleva N, Abdellatif M, Lutucuta S, Kopelen HA, Quinones MA, Zoghbi WA, Entman ML, Roberts R, et al. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation 2001; 104:317-24; PMID:11457751; http://dx.doi.org/10.1161/hc2801.094031
   Google Scholar
• Ganga HV, Slim HB, Thompson PD. A systematic review of statin-induced muscle problems in clinical trials. Am Heart J 2014; 168:6-15; PMID:24952854; http://dx.doi.org/10.1016/j.ahj.2014.03.019
   Google Scholar
• Braamskamp MJ, Kusters DM, Avis HJ, Smets EM, Wijburg FA, Kastelein JJ, Wiegman A, Hutten BA. Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence. Paediatr Drugs 2015; 17:159-66; PMID:25644328; http://dx.doi.org/10.1007/s40272-014-0116-y
   Google Scholar
• Bouitbir J, Charles AL, Echaniz-Laguna A, Kindo M, Daussin F, Auwerx J, Piquard F, Geny B, Zoll J. Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a ‘mitohormesis’ mechanism involving reactive oxygen species and PGC-1. Eur Heart J 2012; 33:1397-407; PMID:21775390; http://dx.doi.org/10.1093/eurheartj/ehr224
   Google Scholar
• Hanai J, Cao P, Tanksale P, Imamura S, Koshimizu E, Zhao J, Kishi S, Yamashita M, Phillips PS, Sukhatme VP, et al. The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity. J Clin Invest 2007; 117:3940-51; PMID:17992259
   Google Scholar
• Chen YW, Nagaraju K, Bakay M, McIntyre O, Rawat R, Shi R, Hoffman EP. Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy. Neurol 2005; 65:826-34; PMID:16093456; http://dx.doi.org/10.1212/01.wnl.0000173836.09176.c4
   Google Scholar
• Gupta A, Gupta Y. Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment. Indian J Endocrinol Metab 2013; 17:913-6; PMID:24083177; http://dx.doi.org/10.4103/2230-8210.117215
   Google Scholar
• Butt AA, Yan P, Bonilla H, Abou-Samra AB, Shaikh OS, Simon TG, Chung RT, Rogal SS, Team ES. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES. Hepatol 2015; 62:365-74; PMID:25847403; http://dx.doi.org/10.1002/hep.27835
   Google Scholar